US20030064505A1 - Device and method for investigating the flowability of a physiological fluid sample - Google Patents

Device and method for investigating the flowability of a physiological fluid sample Download PDF

Info

Publication number
US20030064505A1
US20030064505A1 US10/226,958 US22695802A US2003064505A1 US 20030064505 A1 US20030064505 A1 US 20030064505A1 US 22695802 A US22695802 A US 22695802A US 2003064505 A1 US2003064505 A1 US 2003064505A1
Authority
US
United States
Prior art keywords
measuring particles
fluid sample
measuring
orientation
passage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/226,958
Other versions
US6955923B2 (en
Inventor
Herbert Harttig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics Operations Inc
Original Assignee
Roche Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Corp filed Critical Roche Diagnostics Corp
Assigned to ROCHE DIAGNOSTICS CORPORATION reassignment ROCHE DIAGNOSTICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ROCHE DIAGNOSTICS GMBH
Assigned to ROCHE DIAGNOSTICS GMBH reassignment ROCHE DIAGNOSTICS GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HARTTIG, HERBERT
Publication of US20030064505A1 publication Critical patent/US20030064505A1/en
Assigned to ROCHE DIAGNOSTICS OPERATIONS, INC. reassignment ROCHE DIAGNOSTICS OPERATIONS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ROCHE DIAGNOSTICS CORPORATION
Application granted granted Critical
Publication of US6955923B2 publication Critical patent/US6955923B2/en
Adjusted expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4905Determining clotting time of blood
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/11Automated chemical analysis
    • Y10T436/117497Automated chemical analysis with a continuously flowing sample or carrier stream
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575Volumetric liquid transfer

Definitions

  • the invention concerns a device and a method for investigating the flowability of a physiological fluid sample, in particular a blood sample for coagulation tests, according to the preamble of claims 1 and 21, respectively.
  • a coagulation test system of this type was made known in U.S. Pat. No. 5,110,727. With this system, blood coagulation or coagulation-dissolution tests are to be made possible ex vivo using simple means, e.g., to monitor the effect of anti-coagulants.
  • Iron oxide particles are used as measuring particles in this system, which said iron oxide particles are dispersed in the sample in a measuring capillary and are subjected to an oscillating magnetic field. As a result, the measuring particles move in step with the magnetic field changes and change accordingly in terms of transparency or reflectivity in the measuring range of a detector unit. As sample clotting increases, the particle movement is inhibited, and the measuring signal remains constant.
  • a magnet system comprising a bias-voltage permanent magnet and an electromagnet operated using alternating current are used as actuator.
  • relatively large coils and high currents must be used, which is disadvantageous in terms of weight and power supply, especially in the case of a portable device.
  • the invention is based on the object of preventing the disadvantages of the related art, and improving a measuring system of the type described initially so that reliable and reproducible test results are obtained with simple handling and minimal instrument expense.
  • the actuator device is formed by means of a pump unit for producing a flow of the fluid sample that represents the change in orientation of the measuring particles and travels back and forth along the uptake passage.
  • a pump unit for producing a flow of the fluid sample that represents the change in orientation of the measuring particles and travels back and forth along the uptake passage.
  • This makes it possible to use non-magnetic measuring particles, which can be optimized further in terms of the detection method.
  • an oscillating flow can be produced with low energy consumption and simple constructive means.
  • the system according to the invention does not require expensive manipulation, and makes an automatic measuring sequence possible using the smallest quantities of sample. Since the movement of the measuring particles is induced by means of an alternating flow, production tolerances and the internal surface properties of the sample uptake passage play a subordinate role, and susceptibility to air bubble inclusions is minimized.
  • the pump unit comprises an, in particular, mechanically, pneumatically or piezoelectrically actuated displacer to act on the fluid sample in the uptake passage using suction and pressure in a cyclically alternating fashion.
  • the pump unit comprises a flexible displacement membrane that partially borders the uptake passage.
  • the pump unit should be connected to a pump site in the region of a closed or closeable end portion of the uptake passage.
  • a further advantageous embodiment of the invention provides that the uptake passage is designed—at least in sections—as a capillary passage. This makes it possible to investigate the smallest sample quantities, and the sample fluid can be taken up in a self-suctioning fashion. In addition, high flow gradients and, therefore, an effective orientation of the measuring particles is achieved via a capillary cross-section.
  • the measuring particles are nonspherical, long-straggling and/or flattened in shape. As a result, the particles become oriented transverse to the direction of flow in the shear field of the sample flow, so that, ultimately, a high detection sensitivity can be achieved. It is hereby favorable if the ratio of the longitudinal dimension to the transverse dimension of the measuring particle is greater than 2, preferably greater than 10.
  • the measuring particles are preferably designed as pigments, preferably as platelet-shaped effect pigments, or as rod-shaped or fiber-shaped formations, in particular as whiskers.
  • the measuring particles are suspended as a foreign substance, although it is also feasible that the measuring particles are formed by sample components, in particular erythrocytes in a whole blood sample.
  • the detector device comprises a radiation source and a radiation receiver for electromagnetic radiation, preferably a light diode and an optoelectronic semiconductor sensor.
  • the detection is advantageously based on the fact that the measuring particles absorb and/or reflect incident electromagnetic radiation differently depending on the angle of incidence.
  • the walls of the uptake passage should be permeable to the measuring radiation of the detector device, at least in sections.
  • the uptake passage is coupled to a tempering device for adjusting a specified temperature of the fluid sample.
  • An evaluation unit is provided for the automatic determination of a test parameter according to the change in orientation of the measuring particles detected as a function of time.
  • a measuring device having a capillary passage to take up a blood sample containing measuring particles or to which measuring particles have been added, a pump unit for producing a flow of the blood sample that varies the orientation of the measuring particles and travels back and forth along the uptake passage, and a detector device for the preferably optical detection of the change in orientation of the measuring particles.
  • the object described hereinabove is attained in that a flow of the fluid sample traveling back and forth in the uptake passage is produced for the cyclically changeable orientation of the measuring particles.
  • the fluid sample is subjected to a shear flow in the uptake passage, so that the measuring particles are oriented in synchroneity depending on the direction of flow.
  • the change in orientation of the measuring particles is detected as an alternating change in the reflectance or absorption capability of the fluid sample using an optical detector device.
  • the change in orientation of measuring particles is recorded via a plurality of cycles, and is evaluated as a function of time to determine a variable, in particular the prothrombin time (PT), the activated clotting time (ACT) or the activated partial thromboplastin time (aPTT).
  • PT prothrombin time
  • ACT activated clotting time
  • aPTT activated partial thromboplastin time
  • FIG. 1 is a view of a block diagram of a device or a measuring system for performing coagulation tests on blood samples;
  • FIG. 2 is a view showing the measuring system in illustrative fashion
  • FIGS. 3 and 4 are views of a sample carrier of the measuring system with an uptake passage for a blood sample in top view and vertical cut;
  • FIG. 5 is a sectional view of the uptake passage with measuring particles located therein in the case of back and forth flow;
  • FIG. 6 is a time diagram of a measuring signal reflecting the change in orientation of measuring particles.
  • FIG. 7 shows a slow-motion section of the signal behavior according to FIG. 6.
  • the measuring device shown in the drawing for performing coagulation tests on blood samples basically comprises a sample carrier 10 having an uptake passage 12 for a blood sample 16 to which measuring particles 14 have been added, a pump unit 18 for producing a back and forth flow of the blood sample in the uptake passage, and a detector device 20 , 22 for the optical detection of the flow-induced change in orientation of measuring particles 14 as an indirect measure of viscosity.
  • the sample carrier 10 shown in FIGS. 3 and 4 comprises a multi-layered plastic interconnection body, a rigid base plastic sheet film 24 , an intermediate plastic sheet film 26 and a flexible, transparent cover plastic sheet film 28 .
  • a recess forming the uptake passage 12 is stamped in the intermediate plastic sheet film, which said recess comprises a capillary-shaped passage section 30 and a sample uptake chamber 30 attached thereto on the opening side, and a pump chamber 34 .
  • the sample uptake chamber 32 can be filled via an intake opening 36 in the cover plastic sheet film 28 , while the pump chamber 34 communicates with the atmosphere via a vent opening 38 in the cover plastic sheet film 28 .
  • the pump unit 18 can comprise a stamp 42 driven by means of a piston drive 40 , which said stamp can be placed on the cover plastic sheet film 28 over the pump chamber 34 and close the vent opening 38 .
  • the flexible cover plastic sheet film 28 thereby functions as displacer 44 for acting on the blood sample in the uptake passage 12 with suction and pressure in a cyclically alternating fashion.
  • pneumatically or piezoelectrically-operating actuation means can be used to produce a back and forth-moving fluid stream.
  • the detector device includes a light diode 20 as radiation source that radiates through the cover plastic sheet film 28 into the capillary portion 30 of the uptake passage 12 , as well as a photosensor 22 oriented accordingly to detect the measurement radiation 46 reflected by the blood sample or radiated through said blood sample.
  • the measuring principle is based on the fact that the orientation of measuring particles located in the blood sample changes depending on the sample viscosity by means of the pressure change acting on the blood sample, which can be detected via the change in optical properties in the beam path of the detector device 20 , 22 . As long as the blood sample is in motion, the optical properties fluctuate. If coagulation occurs, they remain constant.
  • a heating device 48 is provided that is in thermally-conductive contact with the uptake passage 12 via the base plastic sheet film 24 .
  • the control of the measuring sequence takes place via a control device 50 connected to the units 18 , 20 , 48 on the output side.
  • a measuring amplifier 52 For the further processing and evaluation of the measuring signals of the photosensor 22 , a measuring amplifier 52 , a signal recorder 54 , an evaluation unit 56 with real-time clock, and a display unit 58 are provided.
  • the evaluation unit 56 includes an A/D converter installed after the measuring amplifier 52 for the time-dependent digitization of the measuring signal, and a digital processing unit designed as a microcontroller for determining test parameters from the signal behavior.
  • the entire measuring device can be placed in a portable-battery-operated manual device, so that the intended tests can be carried out regardless of location.
  • the measuring particles 14 are subjected to a shear flow in the capillary portion 30 of the uptake passage 12 , as illustrated using the flow arrows for the two directions of flow shown.
  • the flow rate v is therefore greatest in the middle of the passage, and it diminishes toward the passage wall 60 in the case of laminar flow in the form of a parabola.
  • this leads to a transverse orientation of the measuring particles 14 that is identical for all said measuring particles, with their longitudinal axes transverse or diagonal to the direction of flow at that instant, whereby a corresponding change in orientation takes place based on the periodic reversal of flow.
  • Platelet-shaped pigments and special effect pigments are preferably provided as suitable anisotropic measuring particles.
  • the property of these pigments to reflect or absorb the incident electromagnetic radiation depending on the angle is significant for the detection, so that pronounced changes in brightness are retained depending on the respective orientation angle.
  • Interference effect pigments are composed of a flat mica plate as the carrier, which said mica plate is coated with a heavily-refracting metal oxide such as titanium dioxide. If the coating is thin, silver-white colors occur. As the thickness of the coating increases, however, yellow, red, blue and, finally, green pearly lustre pigments are obtained.
  • a heavily-refracting metal oxide such as titanium dioxide.
  • Such pigments are supplied by various manufacturers, such as Merck, KGaA, Darmstadt, Germany, under the trade name Iriodin.
  • the surface of the pigments used can be modified using polymeric or oligomeric protective layers.
  • Suitable protective layers of this type include uncharged, synthetic polymers (such as polyethylene, polypropylene, polysilicone, polytetrafluoroethylene, and polystyrene), hydrophilic, uncharged polymers (such as polyethylene glycol, polyvinyl pyrrolidone), or positively-charged polymers, such as heparin derivatives.
  • These polymers or oligomers of them can be fixed on the pigment surface in different fashions, in particular by means of chemical bonding or simple coating, as is the case in terms of coating with polystyrene from solution). Layers based on polyethyleneglycol or polyvinyl pyrrolidone are particularly preferred.
  • the uptake passage 12 is coated on its internal surface with a reagent mixture containing thromboplastins as well as the measuring particles 14 .
  • a sufficient aliquot of a blood sample e.g., 50 ⁇ l are applied to the sample application chamber 32 using a transfer instrument, and suctioned into the uptake passage 12 automatically by means of capillary effect. Any air that is present escapes through the vent opening 38 .
  • the reagent mixture is taken up in the inflowing blood, and the measuring particles (e.g., 0.2 mg effect pigments) are thereby distributed.
  • a constant temperature of 39° C. for example, is maintained by means of a heating device 48 .
  • a low-frequency pressure and suction-producing change of stroke is carried out on the blood sample in the passage 12 using the pump unit 18 in the range of a few Hertz. Due to the flow-induced movement of the measuring particles 14 , the brightness changes in the detection range of the detector device 20 , 22 with the same frequency. Accordingly, an oscillating AC signal is available at the output of the amplifier 52 , as shown in FIGS. 6 and 7 in random units over time. During one initial increase interval, the measuring particles 14 move back and forth in stacked formation in the shear field of the flow increasingly in synchroneity. As soon as coagulation occurs, the motion is inhibited and the signal amplitude drops off accordingly.
  • a test parameter for the blood coagulation reaction such as prothrombin time
  • a suitable algorithm in the evaluation unit 56 with consideration for specific influencing variables and scaling factors.
  • the flow behavior or viscosity changes can be investigated not only in blood samples, but in any fluid samples and, in particular, in other physiological fluids such as plasma, saliva, tissue fluid, milk, etc.
  • additives such as moistening agents and preservatives, activators and buffers can be added.
  • the sample itself delivers measurable components, e.g., in that erythrocytes are used as disk-shaped measuring particles in a blood sample.
  • contactless e.g., capacitively-functioning detection methods.

Abstract

To investigate the flowability of a physiological fluid sample, an uptake passage (12) for the fluid sample (16), an actuator device (18) for the cyclic change in orientation of measuring particles (14) in the fluid sample (16), and a detector device (20, 22) for the preferably optical detection of the change in orientation of the measuring particles (14) are provided. In order to make reliable measurements possible with minimal instrument expense, it is proposed that the actuator device is formed by a pump unit (18) to produce a flow of the fluid sample (16) that travels back and forth along the uptake passage (12) and indicates the change in orientation of the measuring particles (14).

Description

  • The invention concerns a device and a method for investigating the flowability of a physiological fluid sample, in particular a blood sample for coagulation tests, according to the preamble of claims 1 and 21, respectively. [0001]
  • A coagulation test system of this type was made known in U.S. Pat. No. 5,110,727. With this system, blood coagulation or coagulation-dissolution tests are to be made possible ex vivo using simple means, e.g., to monitor the effect of anti-coagulants. Iron oxide particles are used as measuring particles in this system, which said iron oxide particles are dispersed in the sample in a measuring capillary and are subjected to an oscillating magnetic field. As a result, the measuring particles move in step with the magnetic field changes and change accordingly in terms of transparency or reflectivity in the measuring range of a detector unit. As sample clotting increases, the particle movement is inhibited, and the measuring signal remains constant. A magnet system comprising a bias-voltage permanent magnet and an electromagnet operated using alternating current are used as actuator. In order to ensure that the necessary flux density changes are achieved, relatively large coils and high currents must be used, which is disadvantageous in terms of weight and power supply, especially in the case of a portable device. [0002]
  • Based on this, the invention is based on the object of preventing the disadvantages of the related art, and improving a measuring system of the type described initially so that reliable and reproducible test results are obtained with simple handling and minimal instrument expense. [0003]
  • The combination of features indicated in claim 1 and claim 21 is proposed in order to attain this object. Advantageous embodiments and further developments of the invention result from the dependent claims. [0004]
  • With regard for a measuring system, it is proposed according to the invention, that the actuator device is formed by means of a pump unit for producing a flow of the fluid sample that represents the change in orientation of the measuring particles and travels back and forth along the uptake passage. This makes it possible to use non-magnetic measuring particles, which can be optimized further in terms of the detection method. In contrast to a magnetic alternating field, an oscillating flow can be produced with low energy consumption and simple constructive means. The system according to the invention does not require expensive manipulation, and makes an automatic measuring sequence possible using the smallest quantities of sample. Since the movement of the measuring particles is induced by means of an alternating flow, production tolerances and the internal surface properties of the sample uptake passage play a subordinate role, and susceptibility to air bubble inclusions is minimized. [0005]
  • According to a preferred embodiment, it is provided that the pump unit comprises an, in particular, mechanically, pneumatically or piezoelectrically actuated displacer to act on the fluid sample in the uptake passage using suction and pressure in a cyclically alternating fashion. A further design simplification can be achieved in that the pump unit comprises a flexible displacement membrane that partially borders the uptake passage. To produce flow effectively, the pump unit should be connected to a pump site in the region of a closed or closeable end portion of the uptake passage. [0006]
  • In terms of production engineering, it is advantageous for larger piece numbers in particular when the uptake passage is formed by a recess in an intermediate layer of a multi-layered plastic sheet film interconnection body. [0007]
  • A further advantageous embodiment of the invention provides that the uptake passage is designed—at least in sections—as a capillary passage. This makes it possible to investigate the smallest sample quantities, and the sample fluid can be taken up in a self-suctioning fashion. In addition, high flow gradients and, therefore, an effective orientation of the measuring particles is achieved via a capillary cross-section. [0008]
  • A further improvement is achieved in that the measuring particles are nonspherical, long-straggling and/or flattened in shape. As a result, the particles become oriented transverse to the direction of flow in the shear field of the sample flow, so that, ultimately, a high detection sensitivity can be achieved. It is hereby favorable if the ratio of the longitudinal dimension to the transverse dimension of the measuring particle is greater than 2, preferably greater than 10. The measuring particles are preferably designed as pigments, preferably as platelet-shaped effect pigments, or as rod-shaped or fiber-shaped formations, in particular as whiskers. [0009]
  • In order to reduce disturbing influences on the sample, it is advantageous when the measuring particles are enclosed in a polymeric or oligomeric protective layer. [0010]
  • In fluid samples without solid particles, the measuring particles are suspended as a foreign substance, although it is also feasible that the measuring particles are formed by sample components, in particular erythrocytes in a whole blood sample. [0011]
  • In a preferred embodiment, the detector device comprises a radiation source and a radiation receiver for electromagnetic radiation, preferably a light diode and an optoelectronic semiconductor sensor. The detection is advantageously based on the fact that the measuring particles absorb and/or reflect incident electromagnetic radiation differently depending on the angle of incidence. For direct detection, the walls of the uptake passage should be permeable to the measuring radiation of the detector device, at least in sections. [0012]
  • In order to create reproducible measuring conditions, it is advantageous if the uptake passage is coupled to a tempering device for adjusting a specified temperature of the fluid sample. [0013]
  • An evaluation unit is provided for the automatic determination of a test parameter according to the change in orientation of the measuring particles detected as a function of time. [0014]
  • To perform coagulation tests, the following are proposed in particular: a measuring device having a capillary passage to take up a blood sample containing measuring particles or to which measuring particles have been added, a pump unit for producing a flow of the blood sample that varies the orientation of the measuring particles and travels back and forth along the uptake passage, and a detector device for the preferably optical detection of the change in orientation of the measuring particles. [0015]
  • In terms of the method, the object described hereinabove is attained in that a flow of the fluid sample traveling back and forth in the uptake passage is produced for the cyclically changeable orientation of the measuring particles. The fluid sample is subjected to a shear flow in the uptake passage, so that the measuring particles are oriented in synchroneity depending on the direction of flow. [0016]
  • In a preferred embodiment, the change in orientation of the measuring particles is detected as an alternating change in the reflectance or absorption capability of the fluid sample using an optical detector device. [0017]
  • To perform coagulation tests, the change in orientation of measuring particles is recorded via a plurality of cycles, and is evaluated as a function of time to determine a variable, in particular the prothrombin time (PT), the activated clotting time (ACT) or the activated partial thromboplastin time (aPTT).[0018]
  • The invention will be described in greater detail hereinbelow with reference to schematic drawings in exemplary embodiments. [0019]
  • FIG. 1 is a view of a block diagram of a device or a measuring system for performing coagulation tests on blood samples; [0020]
  • FIG. 2 is a view showing the measuring system in illustrative fashion; [0021]
  • FIGS. 3 and 4 are views of a sample carrier of the measuring system with an uptake passage for a blood sample in top view and vertical cut; [0022]
  • FIG. 5 is a sectional view of the uptake passage with measuring particles located therein in the case of back and forth flow; [0023]
  • FIG. 6 is a time diagram of a measuring signal reflecting the change in orientation of measuring particles; and [0024]
  • FIG. 7 shows a slow-motion section of the signal behavior according to FIG. 6.[0025]
  • The measuring device shown in the drawing for performing coagulation tests on blood samples basically comprises a [0026] sample carrier 10 having an uptake passage 12 for a blood sample 16 to which measuring particles 14 have been added, a pump unit 18 for producing a back and forth flow of the blood sample in the uptake passage, and a detector device 20, 22 for the optical detection of the flow-induced change in orientation of measuring particles 14 as an indirect measure of viscosity.
  • The [0027] sample carrier 10 shown in FIGS. 3 and 4 comprises a multi-layered plastic interconnection body, a rigid base plastic sheet film 24, an intermediate plastic sheet film 26 and a flexible, transparent cover plastic sheet film 28. A recess forming the uptake passage 12 is stamped in the intermediate plastic sheet film, which said recess comprises a capillary-shaped passage section 30 and a sample uptake chamber 30 attached thereto on the opening side, and a pump chamber 34. The sample uptake chamber 32 can be filled via an intake opening 36 in the cover plastic sheet film 28, while the pump chamber 34 communicates with the atmosphere via a vent opening 38 in the cover plastic sheet film 28.
  • As shown in FIG. 2, the [0028] pump unit 18 can comprise a stamp 42 driven by means of a piston drive 40, which said stamp can be placed on the cover plastic sheet film 28 over the pump chamber 34 and close the vent opening 38. The flexible cover plastic sheet film 28 thereby functions as displacer 44 for acting on the blood sample in the uptake passage 12 with suction and pressure in a cyclically alternating fashion. It is understood that other, in particular, pneumatically or piezoelectrically-operating actuation means can be used to produce a back and forth-moving fluid stream.
  • The detector device includes a [0029] light diode 20 as radiation source that radiates through the cover plastic sheet film 28 into the capillary portion 30 of the uptake passage 12, as well as a photosensor 22 oriented accordingly to detect the measurement radiation 46 reflected by the blood sample or radiated through said blood sample.
  • As described hereinbelow in greater detail, the measuring principle is based on the fact that the orientation of measuring particles located in the blood sample changes depending on the sample viscosity by means of the pressure change acting on the blood sample, which can be detected via the change in optical properties in the beam path of the [0030] detector device 20, 22. As long as the blood sample is in motion, the optical properties fluctuate. If coagulation occurs, they remain constant.
  • In order to bring the fluid sample to a defined measuring temperature, a [0031] heating device 48 is provided that is in thermally-conductive contact with the uptake passage 12 via the base plastic sheet film 24. The control of the measuring sequence takes place via a control device 50 connected to the units 18, 20, 48 on the output side.
  • For the further processing and evaluation of the measuring signals of the [0032] photosensor 22, a measuring amplifier 52, a signal recorder 54, an evaluation unit 56 with real-time clock, and a display unit 58 are provided. The evaluation unit 56 includes an A/D converter installed after the measuring amplifier 52 for the time-dependent digitization of the measuring signal, and a digital processing unit designed as a microcontroller for determining test parameters from the signal behavior. The entire measuring device can be placed in a portable-battery-operated manual device, so that the intended tests can be carried out regardless of location.
  • As shown in FIG. 5, the [0033] measuring particles 14 are subjected to a shear flow in the capillary portion 30 of the uptake passage 12, as illustrated using the flow arrows for the two directions of flow shown. The flow rate v is therefore greatest in the middle of the passage, and it diminishes toward the passage wall 60 in the case of laminar flow in the form of a parabola. In the case of given anisotropic particle geometry, this leads to a transverse orientation of the measuring particles 14 that is identical for all said measuring particles, with their longitudinal axes transverse or diagonal to the direction of flow at that instant, whereby a corresponding change in orientation takes place based on the periodic reversal of flow.
  • Platelet-shaped pigments and special effect pigments are preferably provided as suitable anisotropic measuring particles. The property of these pigments to reflect or absorb the incident electromagnetic radiation depending on the angle is significant for the detection, so that pronounced changes in brightness are retained depending on the respective orientation angle. [0034]
  • Interference effect pigments are composed of a flat mica plate as the carrier, which said mica plate is coated with a heavily-refracting metal oxide such as titanium dioxide. If the coating is thin, silver-white colors occur. As the thickness of the coating increases, however, yellow, red, blue and, finally, green pearly lustre pigments are obtained. Such pigments are supplied by various manufacturers, such as Merck, KGaA, Darmstadt, Germany, under the trade name Iriodin. [0035]
  • In order to rule out effects on the coagulation behavior, the surface of the pigments used can be modified using polymeric or oligomeric protective layers. Suitable protective layers of this type include uncharged, synthetic polymers (such as polyethylene, polypropylene, polysilicone, polytetrafluoroethylene, and polystyrene), hydrophilic, uncharged polymers (such as polyethylene glycol, polyvinyl pyrrolidone), or positively-charged polymers, such as heparin derivatives. These polymers or oligomers of them can be fixed on the pigment surface in different fashions, in particular by means of chemical bonding or simple coating, as is the case in terms of coating with polystyrene from solution). Layers based on polyethyleneglycol or polyvinyl pyrrolidone are particularly preferred. [0036]
  • To perform a coagulation test, the [0037] uptake passage 12 is coated on its internal surface with a reagent mixture containing thromboplastins as well as the measuring particles 14. A sufficient aliquot of a blood sample, e.g., 50 μl are applied to the sample application chamber 32 using a transfer instrument, and suctioned into the uptake passage 12 automatically by means of capillary effect. Any air that is present escapes through the vent opening 38. The reagent mixture is taken up in the inflowing blood, and the measuring particles (e.g., 0.2 mg effect pigments) are thereby distributed. In order to ensure a defined sequence of the complex enzymatic reactions, a constant temperature of 39° C., for example, is maintained by means of a heating device 48.
  • To produce the alternating flow, a low-frequency pressure and suction-producing change of stroke is carried out on the blood sample in the [0038] passage 12 using the pump unit 18 in the range of a few Hertz. Due to the flow-induced movement of the measuring particles 14, the brightness changes in the detection range of the detector device 20, 22 with the same frequency. Accordingly, an oscillating AC signal is available at the output of the amplifier 52, as shown in FIGS. 6 and 7 in random units over time. During one initial increase interval, the measuring particles 14 move back and forth in stacked formation in the shear field of the flow increasingly in synchroneity. As soon as coagulation occurs, the motion is inhibited and the signal amplitude drops off accordingly.
  • Based on the signal drop, a test parameter for the blood coagulation reaction, such as prothrombin time, can be determined using a suitable algorithm in the [0039] evaluation unit 56 with consideration for specific influencing variables and scaling factors.
  • It is understood that, according to the principle described hereinabove, the flow behavior or viscosity changes can be investigated not only in blood samples, but in any fluid samples and, in particular, in other physiological fluids such as plasma, saliva, tissue fluid, milk, etc. To modify properties of the medium, additives such as moistening agents and preservatives, activators and buffers can be added. It is possible, in principle, that the sample itself delivers measurable components, e.g., in that erythrocytes are used as disk-shaped measuring particles in a blood sample. Instead of using a geometrical optical detection of particle movement, it is also feasible to use other contactless, e.g., capacitively-functioning detection methods. [0040]

Claims (24)

What is claimed is:
1. A device for investigating the flowability of a physiological fluid sample, in particular a blood sample for coagulation tests, having one uptake passage (12) for the fluid sample (16), an actuator device (18) for the cyclic change in orientation of measuring particles (14) in the fluid sample (16), and a detector device (20, 22) for the preferably optical detection of the change in orientation of the measuring particles (14),
wherein, the actuator device is formed by a pump unit (18) to produce a flow of the fluid sample (16) that travels back and forth along the uptake passage (12) and indicates the change in orientation of the measuring particles (14).
2. The device according to claim 1,
wherein, the pump unit (18) comprises an, in particular, mechanically, pneumatically or piezoelectrically-actuated displacer (44) for acting upon the fluid sample (16) in the uptake passage (12) with suction and pressure in a cyclically changing fashion.
3. The device according to claim 1 or 2,
wherein, the pump unit (18) comprises a flexible displacement membrane (28) that partially borders the uptake passage (12).
4. The device according to one of the claims 1-3,
wherein, the pump unit (18) is connected to a pump site in the region of a closed or closeable end portion (34) of the uptake passage (12).
5. The device according to one of the claims 1-4,
wherein the uptake passage (12) is formed by a recess in an intermediate layer (26) of a multi-layer plastic sheet film interconnecting body (10).
6. The device according to one of the claims 1-5,
wherein the uptake passage (12) is designed as a capillary passage (12), at least in sections.
7. The device according to one of the claims 1-6,
wherein the measuring particles (14) are non-spherical, long-straggling and/or flattened in shape.
8. The device according to one of the claims 1-7,
wherein the ratio of the longitudinal dimension to the transverse dimension of the measuring particles (14) is greater than 2, preferably greater than 10.
9. The device according to one of the claims 1-8,
wherein the measuring particles (14) are designed as platelet-shaped pigments, preferably as effect pigments.
10. The device according to one of the claims 1-8,
wherein the measuring particles (14) are designed as rod-shaped or fiber-shaped formations, in particular as whiskers.
11. The device according to one of the claims 1-10,
wherein the measuring particles (14) are covered with a polymeric or oligomeric protective layer.
12. The device according to one of the claims 1-11,
wherein the measuring particles (14) are suspended in the fluid sample (16) as a foreign substance.
13. The device according to one of the claims 1-11,
wherein the measuring particles (14) are formed by sample components of the fluid sample (16), in particular erythrocytes in a whole blood sample.
14. The device according to one of the claims 1-13,
wherein the detector device (20, 22) includes a radiation source (20) and a radiation receiver (22) for electromagnetic radiation.
15. The device according to one of the claims 1-14,
wherein the detector device (20, 22) includes a light diode (20) and an opto-electronic semiconductor sensor (22).
16. The device according to one of the claims 1-15,
wherein the measuring particles (14) absorb and/or reflect differently incident electromagnetic radiation depending on the angle of incidence.
17. The device according to one of the claims 1-16,
wherein the wall of the uptake passage (12) is permeable to the measuring radiation of the detector device (20, 22), at least in sections.
18. The device according to one of the claims 1-17,
wherein the uptake passage (12) is coupled to a tempering device (48) for adjusting a specified temperature of the fluid sample (16).
19. The device according to one of the claims 1-18,
characterized by an evaluation unit (56) for determining a test parameter according to the change in orientation detected as a function of time.
20. The device for performing coagulation tests having a capillary passage (12) to take up a blood sample containing a measuring particle (14) or to which said measuring particle has been added, a pump unit (18) for producing a flow of the blood sample that varies the orientation of the measuring particles (14) in cyclic fashion and travels back and forth along the capillary passage (12) to preferably optically detect the change in orientation of the measuring particles (14).
21. A method for investigating the flowability of a physiological fluid sample, in particular a blood sample for coagulation tests, in which a fluid sample (16) is brought into a take-up passage (12), measuring particles (14) distributed in the fluid sample (16) are oriented differently in cyclic fashion, and the change in orientation of the measuring particles (14) is detected preferably optically, wherein a flow of the fluid sample (16) traveling back and forth in the uptake passage (12) is produced for the cyclically changeable orientation of the measuring particles (14).
22. The method according to claim 21,
wherein the fluid sample (16) is subjected to a shear flow in the uptake passage (12), so that the measuring particles (14) are oriented differently depending on the direction of flow.
23. The method according to claim 21 or 22,
wherein the change in orientation of the measuring particles (14) is detected as an alternating change in the reflectance or absorption capability of the fluid sample (16) by means of an optical detector device (20, 22).
24. The method according to one of the claims 21-23,
wherein the change in orientation of the measuring particles (14) is recorded via a plurality of cycles, and is evaluated as a function of time to determine a variable, in particular the prothrombin time (PT), the activated clotting time (ACT) or the activated partial thromboplastin time (aPTT).
US10/226,958 2001-08-24 2002-08-23 Device and method for investigating the flowability of a physiological fluid sample Expired - Fee Related US6955923B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10140699.1 2001-08-24
DE10140699A DE10140699A1 (en) 2001-08-24 2001-08-24 Arrangement and method for examining the flowability of a physiological liquid sample

Publications (2)

Publication Number Publication Date
US20030064505A1 true US20030064505A1 (en) 2003-04-03
US6955923B2 US6955923B2 (en) 2005-10-18

Family

ID=7695974

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/226,958 Expired - Fee Related US6955923B2 (en) 2001-08-24 2002-08-23 Device and method for investigating the flowability of a physiological fluid sample

Country Status (4)

Country Link
US (1) US6955923B2 (en)
EP (1) EP1288660B1 (en)
DE (2) DE10140699A1 (en)
ES (1) ES2295267T3 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070035738A1 (en) * 2003-12-19 2007-02-15 Core Laboratories Lp Method and apparatus for determining characteristics of particles in a fluid sample
US20090246078A1 (en) * 2006-03-07 2009-10-01 Jonathan Dean Barnard Electromagnetic Assay
WO2015184433A1 (en) * 2014-05-30 2015-12-03 The General Hospital Corporation Optical thromboelastography systems and methods
US10739239B1 (en) * 2013-10-28 2020-08-11 Ifirst Medical Technologies, Inc. Rotating magnetic disc medical analyzer and coagulation profiler

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544260B2 (en) * 2004-10-20 2009-06-09 Mark Banister Micro thruster, micro thruster array and polymer gas generator
AU2005317188B2 (en) * 2004-12-14 2011-06-09 Mark Banister Actuator pump system
US10208158B2 (en) 2006-07-10 2019-02-19 Medipacs, Inc. Super elastic epoxy hydrogel
EP2227635A2 (en) 2007-12-03 2010-09-15 Medipacs, Inc. Fluid metering device
ES2451541T3 (en) 2008-07-16 2014-03-27 International Technidyne Corporation Device based on cuvette for measurement and testing of blood coagulation
DE102009015395B4 (en) 2009-03-23 2022-11-24 Thinxxs Microtechnology Gmbh Flow cell for treating and/or examining a fluid
WO2011032011A1 (en) 2009-09-10 2011-03-17 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
JP2013531787A (en) 2010-05-25 2013-08-08 アリックス インコーポレイテッド Holographic fluctuation microscope apparatus and method for determining particle motility and / or cell dispersion
CN104302689A (en) 2012-03-14 2015-01-21 麦德医像公司 Smart polymer materials with excess reactive molecules
WO2017044055A1 (en) * 2015-09-08 2017-03-16 Elbuken Caglar Blood coagulation time measurement method and apparatus
DE102017104801B4 (en) 2017-03-08 2020-02-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Particle analysis device
CN109765269B (en) * 2018-12-27 2020-07-28 西安交通大学 Sound wave driven blood coagulation testing system

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3486859A (en) * 1966-10-11 1969-12-30 Greiner Electronic Ag Blood analyzing method and apparatus
US3911728A (en) * 1973-02-19 1975-10-14 Daillet S A Ets Coagulation detection apparatus
US4756884A (en) * 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
US4780418A (en) * 1985-11-19 1988-10-25 Michael Kratzer Method and apparatus for measuring the aggregation of blood platelets or the coagulation of blood
US4849340A (en) * 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
US5039617A (en) * 1989-04-20 1991-08-13 Biotrack, Inc. Capillary flow device and method for measuring activated partial thromboplastin time
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US5302348A (en) * 1992-12-10 1994-04-12 Itc Corporation Blood coagulation time test apparatus and method
US5350676A (en) * 1990-07-10 1994-09-27 Cardiovascular Diagnostics, Inc. Method for performing fibrinogen assays using dry chemical reagents containing magnetic particles
US5591403A (en) * 1994-10-21 1997-01-07 International Technidyne Corporation Portable prothrombin time test apparatus and associated method of performing a prothrombin time test
US5628961A (en) * 1993-10-28 1997-05-13 I-Stat Corporation Apparatus for assaying viscosity changes in fluid samples and method of conducting same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU749386A1 (en) * 1978-02-17 1980-07-23 Всесоюзный кардиологический научный центр АМН СССР Method of determining blood viscosity
AT382971B (en) * 1981-06-16 1987-05-11 Hoffmann La Roche METHOD AND DEVICE FOR MEASURING THE BLOOD CLUTTING TIME

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3486859A (en) * 1966-10-11 1969-12-30 Greiner Electronic Ag Blood analyzing method and apparatus
US3911728A (en) * 1973-02-19 1975-10-14 Daillet S A Ets Coagulation detection apparatus
US4756884A (en) * 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
US4780418A (en) * 1985-11-19 1988-10-25 Michael Kratzer Method and apparatus for measuring the aggregation of blood platelets or the coagulation of blood
US4849340A (en) * 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US5658723A (en) * 1987-04-03 1997-08-19 Cardiovascular Diagnostics, Inc. Immunoassay system using forced convection currents
US5039617A (en) * 1989-04-20 1991-08-13 Biotrack, Inc. Capillary flow device and method for measuring activated partial thromboplastin time
US5350676A (en) * 1990-07-10 1994-09-27 Cardiovascular Diagnostics, Inc. Method for performing fibrinogen assays using dry chemical reagents containing magnetic particles
US5302348A (en) * 1992-12-10 1994-04-12 Itc Corporation Blood coagulation time test apparatus and method
US5628961A (en) * 1993-10-28 1997-05-13 I-Stat Corporation Apparatus for assaying viscosity changes in fluid samples and method of conducting same
US5591403A (en) * 1994-10-21 1997-01-07 International Technidyne Corporation Portable prothrombin time test apparatus and associated method of performing a prothrombin time test

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070035738A1 (en) * 2003-12-19 2007-02-15 Core Laboratories Lp Method and apparatus for determining characteristics of particles in a fluid sample
US7542139B2 (en) * 2003-12-19 2009-06-02 Core Laboratories Lp Method and apparatus for determining characteristics of particles in a fluid sample
US20090246078A1 (en) * 2006-03-07 2009-10-01 Jonathan Dean Barnard Electromagnetic Assay
US10739239B1 (en) * 2013-10-28 2020-08-11 Ifirst Medical Technologies, Inc. Rotating magnetic disc medical analyzer and coagulation profiler
US10823743B1 (en) * 2013-10-28 2020-11-03 Ifirst Medical Technologies, Inc. Methods of measuring coagulation of a biological sample
US11598707B1 (en) 2013-10-28 2023-03-07 Ifirst Medical Technologies, Inc. Medical analyzer and coagulation profiler
US11788941B1 (en) 2013-10-28 2023-10-17 Ifirst Medical Technologies, Inc. Method of using disposable BioMEMS coagulation profiling cartridge
WO2015184433A1 (en) * 2014-05-30 2015-12-03 The General Hospital Corporation Optical thromboelastography systems and methods
US10725018B2 (en) * 2014-05-30 2020-07-28 The General Hospital Corporation Optical thromboelastography systems and methods

Also Published As

Publication number Publication date
EP1288660A3 (en) 2006-05-24
DE10140699A1 (en) 2003-03-13
ES2295267T3 (en) 2008-04-16
EP1288660B1 (en) 2007-11-21
EP1288660A2 (en) 2003-03-05
US6955923B2 (en) 2005-10-18
DE50211247D1 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
US6955923B2 (en) Device and method for investigating the flowability of a physiological fluid sample
CA1326883C (en) Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US4913883A (en) Particle agglutination immunoassay apparatus
CN105531578B (en) Biosensor and its correlation technique
US4849340A (en) Reaction system element and method for performing prothrombin time assay
EP2507620B1 (en) Optical bead assay reader
CN102947900A (en) Detection of magnetic particles and their clustering
JP2015121552A (en) Microelectronic sensor device for detecting label particles
JPH07117546B2 (en) Control device capable of detecting consumption of particle-containing fluid
JP2001504936A (en) Microfabricated diffusion-based chemical sensors
US20110165595A1 (en) Apparatus and methods for processing a whole blood sample
WO2010134005A1 (en) Sensor device for magnetic particles with a high dynamic range
US20160146798A1 (en) Biosensor based on the measurements of clustering dynamics of magnetic particles using a double pass setup
CN208224023U (en) The telecontrol equipment of solid phase surface and solution
US20070158246A1 (en) Coagulation detection
US8367399B2 (en) Method for measuring molecular interactions by measurement of light reflected by planar surfaces
KR20070018125A (en) Method and Apparatus of magnetic force-driven rotational Couette flow system
US20170160187A1 (en) Laser Scanner Particle Counter and Imager
IL92191A (en) Coagulation assay using dry chemical reagents and paramagnetic particles
KR0135782B1 (en) Rapid accurate and simple coagulation assay system which

Legal Events

Date Code Title Description
AS Assignment

Owner name: ROCHE DIAGNOSTICS CORPORATION, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS GMBH;REEL/FRAME:013559/0271

Effective date: 20021017

Owner name: ROCHE DIAGNOSTICS GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARTTIG, HERBERT;REEL/FRAME:013559/0214

Effective date: 20021017

AS Assignment

Owner name: ROCHE DIAGNOSTICS OPERATIONS, INC., INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS CORPORATION;REEL/FRAME:015215/0061

Effective date: 20040101

Owner name: ROCHE DIAGNOSTICS OPERATIONS, INC.,INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS CORPORATION;REEL/FRAME:015215/0061

Effective date: 20040101

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20131018